Viewing nowRosuvastatin Calcium 5 mg Tablets
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
IntroBio Pharma Co., Ltd.

MFDS item code 201901250 · Approved 2019.02.26 · Insurance code 052401140
Improvement of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is primarily used as an adjunct therapy for patients with primary hypercholesterolemia and mixed dyslipidemia that are not controlled by diet and exercise. It also helps to lower cholesterol levels in patients aged 10 years and older with familial hypercholesterolemia. It reduces total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis and aiding patients with dysbetalipoproteinemia in their dietary regimen. Furthermore, it is effective in reducing the risk of stroke, myocardial infarction, and vascular reconstruction in middle-aged individuals with cardiovascular risk factors. Overall, this medication is used to improve cardiovascular health in various conditions related to dyslipidemia.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Geriatric patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Ages 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, it should not be given to those with allergies to its components, unexplained liver dysfunction, muscle diseases, or severe renal impairment. Pregnant or nursing women, as well as fertile women who do not use appropriate contraception, are also advised against using this medication. Additionally, high doses should be avoided in patients prone to muscle diseases. This medication should be used cautiously in patients with poor liver function or those consuming excessive alcohol, and liver function tests should be repeated before and during treatment. If symptoms such as muscle pain or weakness appear, medical personnel should be informed immediately, and blood tests may be necessary to assess muscle damage. This medication can rarely cause severe skin reactions, liver damage, and muscle damage, so discontinuation is essential if such symptoms arise. Interactions may occur when taken with other medications, particularly certain antiviral agents, immunosuppressants, and fibrates, so caution is warranted. Pregnant or nursing women should not use this medication, and women of childbearing potential should use appropriate contraception. In case of overdose, there is no specific antidote; therefore, treatment should align with symptoms while monitoring liver function and muscle enzyme levels. This medication is not known to significantly affect driving or machine operation, but caution is necessary as dizziness may occur. Finally, regular check-ups and consultations with healthcare personnel are important for safe treatment while taking this medication.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced lichenoid rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1°C and 30°C. By storing it this way, the efficacy of the medication can be maintained and deterioration prevented.
Yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
IntroBio Pharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.